Literature DB >> 29849225

Tri-modality treatment in N2 stage IIIa non-small cell lung cancer: proper sequence remains unknown.

Ze-Rui Zhao1, Calvin S H Ng1.   

Abstract

Entities:  

Year:  2018        PMID： 29849225      PMCID： PMC5949436          DOI： 10.21037/jtd.2018.03.69

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  Need for a new trial to evaluate adjuvant postoperative radiotherapy in non-small-cell lung cancer patients with N2 mediastinal involvement.

Authors:  Cecile Le Péchoux; Ariane Dunant; Jean-Pierre Pignon; Dirk De Ruysscher; Françoise Mornex; Suresh Senan; Francesc Casas; Allan Price; Bernard Milleron
Journal:  J Clin Oncol       Date:  2007-03-01       Impact factor: 44.544

2.  Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.

Authors:  Cliff G Robinson; Aalok P Patel; Jeffrey D Bradley; Todd DeWees; Saiama N Waqar; Daniel Morgensztern; Maria Q Baggstrom; Ramaswamy Govindan; Jennifer M Bell; Tracey J Guthrie; Graham A Colditz; Traves D Crabtree; Daniel Kreisel; Alexander S Krupnick; G Alexander Patterson; Bryan F Meyers; Varun Puri
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

3.  Variations in target volume definition for postoperative radiotherapy in stage III non-small-cell lung cancer: analysis of an international contouring study.

Authors:  Femke O B Spoelstra; Suresh Senan; Cecile Le Péchoux; Satoshi Ishikura; Francesc Casas; David Ball; Allan Price; Dirk De Ruysscher; John R van Sörnsen de Koste
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-06-27       Impact factor: 7.038

4.  Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer.

Authors:  Samual Francis; Andrew Orton; Greg Stoddard; Randa Tao; Ying J Hitchcock; Wallace Akerley; Kristine E Kokeny
Journal:  J Clin Oncol       Date:  2017-12-13       Impact factor: 44.544

5.  A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques.

Authors:  B Dautzenberg; R Arriagada; A B Chammard; A Jarema; M Mezzetti; K Mattson; J L Lagrange; C Le Pechoux; B Lebeau; C Chastang
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

6.  Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.

Authors:  Heather A Wakelee; Patricia Stephenson; Steven M Keller; Henry Wagner; Arnold Herskovic; Ritsuko Komaki; Randolph S Marks; Michael C Perry; Robert B Livingston; David H Johnson
Journal:  Lung Cancer       Date:  2005-01-05       Impact factor: 5.705

7.  Patterns of local-regional failure in completely resected stage IIIA(N2) non-small cell lung cancer cases: implications for postoperative radiation therapy clinical target volume design.

Authors:  Wen Feng; Xiao-Long Fu; Xu-Wei Cai; Huan-Jun Yang; Kai-Liang Wu; Min Fan; Jia-Qing Xiang; Ya-Wei Zhang; Hai-Quan Chen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-02-11       Impact factor: 7.038

Review 8.  Postoperative radiotherapy for non-small cell lung cancer.

Authors:  Sarah Burdett; Larysa Rydzewska; Jayne Tierney; David Fisher; Mahesh Kb Parmar; Rodrigo Arriagada; Jean Pierre Pignon; Cecile Le Pechoux
Journal:  Cochrane Database Syst Rev       Date:  2016-09-29

Review 9.  The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.

Authors:  Hisao Asamura; Kari Chansky; John Crowley; Peter Goldstraw; Valerie W Rusch; Johan F Vansteenkiste; Hirokazu Watanabe; Yi-Long Wu; Marcin Zielinski; David Ball; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

10.  Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.

Authors:  George Rodrigues; Hak Choy; Jeffrey Bradley; Kenneth E Rosenzweig; Jeffrey Bogart; Walter J Curran; Elizabeth Gore; Corey Langer; Alexander V Louie; Stephen Lutz; Mitchell Machtay; Varun Puri; Maria Werner-Wasik; Gregory M M Videtic
Journal:  Pract Radiat Oncol       Date:  2015 May-Jun
View more
  2 in total

1.  Adjuvant therapy for resected pN2 non-small cell lung cancer: sequence is not all that matters.

Authors:  Kristine E Kokeny; Samual Francis; Randa Tao; Ying J Hitchcock
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

2.  Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer.

Authors:  Ze-Rui Zhao; Chao-Pin Yang; Si Chen; Hui Yu; Yong-Bin Lin; Yao-Bin Lin; Han Qi; Jie-Tian Jin; Shan-Shan Lian; Yi-Zhi Wang; Jin-Qi You; Wen-Yu Zhai; Hao Long
Journal:  Oncoimmunology       Date:  2021-10-25       Impact factor: 8.110
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.